Clinical Trials

NCT03623490 | TERMINATED | NA

101 participants

Optimizing the Management of Patients With Oral Therapy

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2018-05-22

Completion:

2021-05-11

Conditions

• Kidney Cancer
• Breast Cancer

Interventions

• OTHER

No Results Yet

NCT03592641 | TERMINATED | PHASE2

5 participants

Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2019-07-25

Completion:

2021-07-31

Conditions

• Colorectal Carcinoma
• Metastatic Colon Adenocarcinoma
• Metastatic Rectal Adenocarcinoma
• Stage III Colon Cancer AJCC v8
• Stage III Rectal Cancer AJCC v8
• Stage IIIA Colon Cancer AJCC v8
• Stage IIIA Rectal Cancer AJCC v8
• Stage IIIB Colon Cancer AJCC v8
• Stage IIIB Rectal Cancer AJCC v8
• Stage IIIC Colon Cancer AJCC v8
• Stage IIIC Rectal Cancer AJCC v8
• Stage IV Colon Cancer AJCC v8
• Stage IV Rectal Cancer AJCC v8
• Stage IVA Colon Cancer AJCC v8
• Stage IVA Rectal Cancer AJCC v8
• Stage IVB Colon Cancer AJCC v8
• Stage IVB Rectal Cancer AJCC v8
• Stage IVC Colon Cancer AJCC v8
• Stage IVC Rectal Cancer AJCC v8
• Unresectable Colon Adenocarcinoma
• Unresectable Rectal Adenocarcinoma

Interventions

• DRUG

Results Available

NCT03538119 | COMPLETED | NA

69 participants

Comparison Between HIIT and MICT on the Phase III of Cardiac Rehabilitation

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2018-12-19

Completion:

2022-10-30

Conditions

• Patients With Coronary Artery Disease

Interventions

• OTHER

No Results Yet

NCT03468985 | COMPLETED | PHASE2

3 participants

Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2018-05-07

Completion:

2022-05-09

Conditions

• Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
• Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
• Stage IV Lung Non-Small Cell Cancer AJCC v7

Interventions

• DRUG
• BIOLOGICAL

Results Available

NCT03447912 | COMPLETED | NA

2924 participants

Smoke-free Air Coalitions in Georgia and Armenia

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2018-10-01

Completion:

2022-06-30

Conditions

• Smoking

Interventions

• BEHAVIORAL

Results Available

NCT03434418 | COMPLETED | PHASE2

17 participants

A Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR Mutations

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2018-06-30

Completion:

2022-10-12

Conditions

• Non Small Cell Lung Cancer

Interventions

• DRUG

Results Available

NCT03366103 | TERMINATED | PHASE1/PHASE2

15 participants

Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2018-03-20

Completion:

2021-07-28

Conditions

• Metastatic Malignant Solid Neoplasm
• Recurrent Lung Small Cell Carcinoma
• Recurrent Malignant Solid Neoplasm
• Refractory Malignant Solid Neoplasm
• Stage III Lung Small Cell Carcinoma, by American Joint Committee on Cancer (AJCC) v7
• Stage IIIA Lung Small Cell Carcinoma AJCC v7
• Stage IIIB Lung Small Cell Carcinoma AJCC v7
• Stage IV Lung Small Cell Carcinoma AJCC v7
• Unresectable Solid Neoplasm

Interventions

• BIOLOGICAL
• DRUG

Results Available

NCT03314337 | COMPLETED | NA

120 participants

Pancreatic Stent for Distal Pancreatectomy

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2017-11-01

Completion:

2022-12-01

Conditions

• Distal Pancreatectomy

Interventions

• DEVICE

No Results Yet

NCT03267121 | COMPLETED | PHASE2

38 participants

A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2017-10-01

Completion:

2020-09-30

Conditions

• Head and Neck Squamous Cell Carcinoma

Interventions

• DRUG

No Results Yet

NCT03253679 | COMPLETED | PHASE2

31 participants

AZD1775 in Treating Patients With Advanced Refractory Solid Tumors With CCNE1 Amplification

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2019-01-16

Completion:

2022-10-31

Conditions

• Advanced Malignant Solid Neoplasm
• Refractory Malignant Solid Neoplasm

Interventions

• DRUG

Results Available

NCT03208010 | COMPLETED | NA

300 participants

Diabetes Prevention for Mexican Americans

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2017-04-01

Completion:

2023-07-31

Conditions

• Prediabetic State
• Overweight and Obesity

Interventions

• BEHAVIORAL
• OTHER

No Results Yet

NCT03099148 | COMPLETED | PHASE1

29 participants

A Study of LY3337641 in Healthy Participants

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2017-04-04

Completion:

2017-05-31

Conditions

• Healthy

Interventions

• DRUG

Results Available

NCT03099109 | COMPLETED | PHASE1

209 participants

A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2017-04-12

Completion:

2019-12-10

Conditions

• Solid Tumor

Interventions

• DRUG

No Results Yet

NCT03061474 | COMPLETED | PHASE2

46 participants

Nicotinamide as an Early Alzheimer's Disease Treatment

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2017-07-12

Completion:

2022-08-30

Conditions

• Alzheimer's Disease
• Mild Cognitive Impairment

Interventions

• DRUG

Results Available

NCT03040726 | COMPLETED | PHASE2/PHASE3

53 participants

Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2017-05-03

Completion:

2022-02-14

Conditions

• Malignant Neoplasm
• Nausea
• Vomiting

Interventions

• DRUG
• OTHER

Results Available

NCT02899728 | TERMINATED | PHASE2

9 participants

Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2018-03-30

Completion:

2020-03-17

Conditions

• Extensive Stage Lung Small Cell Carcinoma

Interventions

• DRUG

Results Available

NCT02899065 | COMPLETED | NA

200 participants

Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Department

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2018-03-06

Completion:

2022-04-15

Conditions

• Influenza, Human

Interventions

• DIAGNOSTIC_TEST
• OTHER

Results Available

NCT02894177 | COMPLETED | NA

130 participants

Transcutaneous Carbon Dioxide Pressure (tcPCO2) Monitoring for the Prediction of Extubation Failure in the ICU

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2017-09-04

Completion:

2020-04-02

Conditions

• Ventilator Weaning

Interventions

• PROCEDURE

No Results Yet

NCT02893930 | COMPLETED | PHASE2

13 participants

Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2017-04-28

Completion:

2021-05-11

Conditions

• Pancreatic Neuroendocrine Tumor G1
• Pancreatic Neuroendocrine Tumor G2
• Refractory Pancreatic Neuroendocrine Carcinoma

Interventions

• DRUG

Results Available

NCT02850640 | ACTIVE_NOT_RECRUITING

600 participants

Cost and Medical Care of Patients With Advanced Serious Illness in Singapore (COMPASS) Study

Study Type:

OBSERVATIONAL

Last Updated:

2023-10-17

Start Date:

2015-12-31

Completion:

2024-07-01

Conditions

• Cancer

No Results Yet

NCT02840890 | COMPLETED | NA

94 participants

Osteopathy and Prevention of Gastrointestinal Side Effects in Women Treated for Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2015-11-05

Completion:

2015-11-05

Conditions

• Breast Cancer

Interventions

• PROCEDURE

No Results Yet

NCT02796781 | COMPLETED | PHASE1/PHASE2

15 participants

Autologous Lung Stem Cell Transplantation in Patients With Interstitial Lung Diseases

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2016-10-12

Completion:

2020-08-31

Conditions

• Interstitial Lung Diseases

Interventions

• BIOLOGICAL

No Results Yet

NCT02785562 | COMPLETED | NA

170 participants

Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression.

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2016-07-21

Completion:

2020-04-06

Conditions

• Lung Cancer

Interventions

• OTHER

No Results Yet

NCT02780804 | COMPLETED | PHASE1

21 participants

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2017-01-06

Completion:

2021-06-30

Conditions

• Brain Stem Neoplasm
• Pineal Region Neoplasm
• Recurrent Lymphoma
• Recurrent Malignant Solid Neoplasm
• Recurrent Primary Central Nervous System Neoplasm
• Recurrent Visual Pathway Glioma
• Refractory Lymphoma
• Refractory Malignant Solid Neoplasm
• Refractory Primary Central Nervous System Neoplasm
• Refractory Visual Pathway Glioma

Interventions

• DRUG
• OTHER

Results Available

NCT02629393 | COMPLETED | PHASE2/PHASE3

5 participants

Study of ORGN001 (Formerly ALXN1101) in Neonates, Infants and Children With Molybdenum Cofactor Deficiency (MOCD) Type A

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2016-05-31

Completion:

2022-09-30

Conditions

• Molybdenum Cofactor Deficiency, Type A

Interventions

• DRUG

Results Available

NCT02604459 | TERMINATED | NA

145 participants

Does Optimized General Anesthesia Care Reduce Postoperative Delirium?

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2015-06-01

Completion:

2018-02-28

Conditions

• Hip Fractures
• Anesthesia
• Delirium

Interventions

• DEVICE
• PROCEDURE
• DRUG

Results Available

NCT02500797 | COMPLETED | PHASE2

164 participants

Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2015-08-13

Completion:

2019-04-01

Conditions

• Locally Advanced Bone Sarcoma
• Locally Advanced Dedifferentiated Liposarcoma
• Locally Advanced Gastrointestinal Stromal Tumor
• Locally Advanced Soft Tissue Sarcoma
• Metastatic Bone Sarcoma
• Metastatic Liposarcoma
• Metastatic Soft Tissue Sarcoma
• Metastatic Undifferentiated Pleomorphic Sarcoma
• Metastatic Unresectable Sarcoma
• Pleomorphic Liposarcoma
• Stage III Bone Sarcoma AJCC v7
• Stage III Soft Tissue Sarcoma AJCC v7
• Stage IV Bone Sarcoma AJCC v7
• Stage IV Soft Tissue Sarcoma AJCC v7
• Stage IVA Bone Sarcoma AJCC v7
• Stage IVB Bone Sarcoma AJCC v7
• Unresectable Bone Sarcoma
• Unresectable Dedifferentiated Liposarcoma
• Unresectable Liposarcoma
• Unresectable Malignant Gastrointestinal Stromal Tumor
• Unresectable Soft Tissue Sarcoma

Interventions

• BIOLOGICAL
• OTHER

Results Available

NCT02304458 | COMPLETED | PHASE1/PHASE2

140 participants

Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2015-03-30

Completion:

2021-09-30

Conditions

• Metastatic Melanoma
• Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
• Recurrent Hodgkin Lymphoma
• Recurrent Malignant Solid Neoplasm
• Recurrent Melanoma
• Recurrent Neuroblastoma
• Recurrent Non-Hodgkin Lymphoma
• Recurrent Osteosarcoma
• Recurrent Rhabdomyosarcoma
• Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
• Refractory Hodgkin Lymphoma
• Refractory Malignant Solid Neoplasm
• Refractory Melanoma
• Refractory Neuroblastoma
• Refractory Non-Hodgkin Lymphoma
• Refractory Osteosarcoma
• Refractory Rhabdomyosarcoma
• Stage III Cutaneous Melanoma AJCC v7
• Stage IIIA Cutaneous Melanoma AJCC v7
• Stage IIIB Cutaneous Melanoma AJCC v7
• Stage IIIC Cutaneous Melanoma AJCC v7
• Stage IV Cutaneous Melanoma AJCC v6 and v7
• Unresectable Melanoma

Interventions

• BIOLOGICAL
• OTHER

Results Available

NCT02136147 | COMPLETED

632 participants

ADHD Medication and Predictors of Treatment Outcome

Study Type:

OBSERVATIONAL

Last Updated:

2023-10-17

Start Date:

2015-06-30

Completion:

2021-07-31

Conditions

• Attention Deficit Disorder With Hyperactivity (ADHD)

Interventions

• DRUG

No Results Yet

NCT02090101 | COMPLETED | PHASE2

32 participants

Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2014-10-10

Completion:

2014-10-10

Conditions

• Metastatic Colorectal Cancer

Interventions

• DRUG

No Results Yet

NCT02047461 | COMPLETED | PHASE2

8 participants

Safety & Efficacy Study of ORGN001 (Formerly ALXN1101) in Pediatric Patients With MoCD Type A Currently Treated With rcPMP

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2014-04-30

Completion:

2022-08-31

Conditions

• Molybdenum Cofactor Deficiency, Type A

Interventions

• DRUG

Results Available

NCT02017704 | COMPLETED | PHASE2

9 participants

Chemoradiation or Brachytherapy for Rectal Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2014-06-12

Completion:

2021-09-30

Conditions

• Rectal Cancer

Interventions

• RADIATION
• DRUG
• PROCEDURE

Results Available

NCT02005471 | COMPLETED | PHASE3

389 participants

A Study to Evaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2014-03-17

Completion:

2017-05-08

Conditions

• Chronic Lymphocytic Leukemia

Interventions

• DRUG

Results Available

NCT01956058 | COMPLETED | PHASE2

30 participants

Brachytherapy for Recurrent Prostate Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2013-03-26

Completion:

2013-03-26

Conditions

• Recurrent Prostate Cancer
• Brachytherapy Remedial

Interventions

• RADIATION

No Results Yet

NCT01949311 | COMPLETED | PHASE3

2733 participants

Open-label Study of Dupilumab in Patients With Atopic Dermatitis

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2013-10-10

Completion:

2022-06-27

Conditions

• Atopic Dermatitis

Interventions

• DRUG

Results Available

NCT01711658 | COMPLETED | PHASE2

142 participants

TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2013-03-15

Completion:

2020-12-01

Conditions

• Non-HPV Locally Advanced Head and Neck Cancer

Interventions

• RADIATION
• DRUG

Results Available

NCT01698008 | COMPLETED | NA

5 participants

Effect of Mobile Phone Telemedicine on Diabetes Care

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2012-01-28

Completion:

2013-09-25

Conditions

• Diabetes Mellitus

Interventions

• OTHER

Results Available

NCT01622868 | COMPLETED | PHASE2

143 participants

Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2012-12-06

Completion:

2019-12-30

Conditions

• HER2-Positive Breast Carcinoma
• Invasive Breast Carcinoma
• Metastatic Malignant Neoplasm in the Brain
• Recurrent Breast Carcinoma
• Stage IV Breast Cancer AJCC v6 and v7

Interventions

• OTHER
• DRUG
• RADIATION

Results Available

NCT01513408 | ACTIVE_NOT_RECRUITING | NA

500 participants

Relevance of T Lymphocytes Tumor Infiltrates CD8 and Foxp3 as Immune Prognostic Biomarker in Breast Cancer Treated by Neo Adjuvant Chemotherapy

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2012-05-31

Completion:

2015-10-31

Conditions

• Breast Cancer

Interventions

• OTHER

No Results Yet

NCT00566345 | COMPLETED | PHASE3

3670 participants

Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)

Study Type:

INTERVENTIONAL

Last Updated:

2023-10-17

Start Date:

2007-11-30

Completion:

2008-06-30

Conditions

• Influenza

Interventions

• BIOLOGICAL
• OTHER

Results Available